Conceptos Categóricos

EXERCICIO FISICO EM PACIENTES COM SINDROME DE MARFAN
Artículos relacionadosArtículos relacionadosArtículos relacionados
Artículos afines de siicsalud publicados en los últimos 4 meses
ASPIRINA PARA LA PREVENCIÓN SECUNDARIA DE EVENTOS CARDIOVASCULARES
American College of Cardiology
Difundido en siicsalud: 18 oct 2021

EXERCICIO FISICO EM PACIENTES COM SINDROME DE MARFAN

(especial para SIIC © Derechos reservados)
A prescrição (La prescripción) de exercícios físicos para pacientes com Síndrome de Marfan tem sido um (ha sido un) desafio. Porém (Todavía), avaliações clínicas e laboratoriais (evaluaciones clínicas y de laboratorio) minuciosas, associados ao (al) crescente número de pesquisas na área e ao conceito (en el área y al concepto) de especificidade de treinamento fortalecem a indicação e a segurança (refuerzan la indicación y la seguridad) de um programa de exercícios físicos.
Autor:
Wladimir Musetti Medeiros
Columnista Experto de SIIC

Institución:
Universidade Federal de São Paulo - UNIFESP


Artículos publicados por Wladimir Musetti Medeiros
Coautor
Paulo Alberto Peres* 
Kinesiólogo, Universidade Nove de Julho (Uninove), San Pablo, Brasil*
Recepción del artículo
2 de Febrero, 2015
Aprobación
3 de Marzo, 2015
Primera edición
22 de Abril, 2015
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
A síndrome de Marfan é uma doença autossômica (una enfermedad autosómica) dominante, com prevalência de 1/5 000 indivíduos, causada por uma mutação no cromossomo 15. Essa mutação acarreta em disfunção na síntese de fibrilina (conduce a la disfunción en la síntesis de la fibrilina) e consequentemente em alterações em diversos sistemas. Caracteriza-se principalmente por desordens musculoesqueléticas, cardiovasculares, pulmonares e oculares. Estatura elevada, pectus excavatum, escoliose, cifose (cifosis), hipermobilidade articular, dilatação e dissecção aórtica, prolapso de válvula mitral, regurgitação aórtica (regurgitación aórtica) e alterações oculares são achados comuns (son hallazgos comunes). Esse conjunto de alterações sistêmicas tem dificultado uma importante intervenção terapêutica, o exercício físico. Embora (Aunque) alguns estudos tenham explorado o impacto agudo e crônico desta intervenção, a literatura ainda é (la literatura aún es) bastante carente de informações. As revisões sobre exercício físico e a síndrome de Marfan têm abordado adequadamente as manifestações clínicas da doença e o manejo do (y el manejo del) paciente com síndrome de Marfan. Entretanto, pouco tem-se explorado sobre a interação dos (Sin embargo, poco se ha explorado respectodea la interacción de los) diversos sistemas fisiológicos e o exercício físico. A presente revisão tem como propósito trazer a luz (sacar a la luz) dos leitores não só os aspectos sobre a interação entre os sistemas e o exercício, mas também um prescrição mais detalhada de um programa de exercícios físico para o paciente com síndrome de Marfan. A prescrição (La prescripción) de exercícios físicos para pacientes com Síndrome de Marfan tem sido um (ha sido un) desafio. Porém (Todavía) , avaliações clínicas e laboratoriais (evaluaciones clínicas y de laboratorio) minuciosas, associados ao (al) crescente número de pesquisas na área e ao conceito (en el área y al concepto) de especificidade de treinamento fortalecem a indicação e a segurança (refuerzan la indicación y la seguridad) de um programa de exercícios físicos.

Palabras clave
síndrome de Marfan, síndrome de Marfan, exercício físico, ejercicio físico, exercício resistido, ejercicio de resistencia, prescrição do exercício, prescripción de ejercicio, doença cardiovascular, enfermedad cardiovascular


Artículo completo

(castellano)
Extensión:  +/-11.76 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Marfan syndrome is an autosomal dominant disorder with a prevalence of 1/5 000 individuals, caused by a mutation on chromosome 15. This mutation leads to dysfunction in the synthesis of fibrillin and consequently in disorders in various systems. It is mainly characterized by alterations in musculoskeletal, cardiovascular, pulmonary and ocular system. Tall stature, pectus excavatum, scoliosis, kyphosis, joint hypermobility, dilatation and aortic dissection, mitral valve prolapse, aortic regurgitation are common findings. This group of systemic changes have hampered an important therapeutic intervention, the exercise. Although some studies have explored the acute and chronic impact of this intervention, the literature is still lacking in information. The reviews on exercise and Marfan syndrome have adequately addressed the clinical manifestations of the disease and the management of patients with Marfan syndrome. However, little has been explored about the interaction of several physiological systems and physical exercise. The present review aims to bring to light of the readers not only the aspects of the interaction between systems and exercise, but also a more detailed prescription of a program of physical exercises for patients with Marfan syndrome. The prescription of exercise for patients with Marfa syndrome has been a challenge. However, detailed clinical and laboratory evaluations, associated with the growing body of research in the area and the concept of specificity of training reinforce the indication and safety of an exercise program.

Key words
Marfan syndrome, physical exercise, resistance exercise, exercise prescription, cardiovascular disease


Full text
(english)
para suscriptores/ assinantes

Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Cardiología, Fisiatría
Relacionadas: Kinesiología, Medicina Deportiva, Neumonología, Ortopedia y Traumatología



Comprar este artículo
Extensión: 11.76 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Wladimir Musetti Medeiros, 04020-050, Rua Prof. Francisco de Castro 54, São Paulo, Brasil
Bibliografía del artículo
1. Exercise for health. WHO/FIMS Committee on Physical Activity for Health. Bulletin of the World Health Organization 73(2):135-6, 1995.
2. Dean JC. Management of Marfan syndrome. Heart 88(1):97-103, 2002.
3. Krause KJ. Marfan syndrome: literature review of mortality studies. Journal of Insurance Medicine 32(2):79-88, 2000.
4. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62(4):417-26, 1996.
5. Lipscomb KJ, Clayton-Smith J, Harris R. Evolving phenotype of Marfan's syndrome. Archives of Disease in Childhood 76(1):41-6, 1997. PubMed PMID: 9059160.
6. Silverman DI, Burton KJ, Gray J, Bosner MS, Kouchoukos NT, Roman MJ, y col. Life expectancy in the Marfan syndrome. Am J Cardiol 75(2):157-60, 1995.
7. Morse RP, Rockenmacher S, Pyeritz RE, Sanders SP, Bieber FR, Lin A, y col. Diagnosis and management of infantile marfan syndrome. Pediatrics 86(6):888-95, 1990.
8. Cabrera-Bueno F, Gallego García de Vinuesa P, Evangelista-Masip A. Nuevos criterios diagnósticos en el síndrome de Marfan. Cardiocore 46(3):85-8, 2011.
9. Giampietro PF, Raggio C, Davis JG. Marfan syndrome: orthopedic and genetic review. Current Opinion in Pediatrics 14(1):35-41, 2002.
10. Streeten EA, Murphy EA, Pyeritz RE. Pulmonary function in the Marfan syndrome. Chest 91(3):408-12, 1987.
11. Cipriano GF, Brech GC, Peres PA, Mendes CC, Cipriano G, Jr., Carvalho AC. Anthropometric and musculoskeletal assessment of patients with Marfan syndrome. Rev Bras Fisioter 15(4):291-6, 2011.
12. Cipriano GF, Peres PA, Cipriano G, Jr., Arena R, Carvalho AC. Safety and cardiovascular behavior during pulmonary function in patients with Marfan syndrome. Clinical Genetics 78(1):57-65, 2010.
13. Malek MH, Coburn JW. Strategies for cardiopulmonary exercise testing of pectus excavatum patients. Clinics (Sao Paulo) 63(2):245-54, 2008.
14. Jayaramakrishnan K, Wotton R, Bradley A, Naidu B. Does repair of pectus excavatum improve cardiopulmonary function? Interactive Cardiovascular and Thoracic Surgery 16(6):865-70, 2013.
15. Vanti C, Generali A, Ferrari S, Nava T, Tosarelli D, Pillastrini P. General postural rehabilitation in musculoskeletal diseases: scientific evidence and clinical indications. Reumatismo 59(3):192-201, 2007.
16. Guimaraes GV, Carvalho VO, Bocchi EA, D'Avila VM. Pilates in heart failure patients: a randomized controlled pilot trial. Cardiovascular Therapeutics 30(6):351-6, 2012.
17. Cruz-Ferreira A, Fernandes J, Kuo YL, Bernardo LM, Fernandes O, Laranjo L, y col. Does pilates-based exercise improve postural alignment in adult women? Women & Health 53(6):597-611, 2013.
18. Seidi F, Rajabi R, Ebrahimi I, Alizadeh MH, Minoonejad H. The efficiency of corrective exercise interventions on thoracic hyper-kyphosis angle. Journal of Back and Musculoskeletal Rehabilitation 27(1):7-16, 2014.
19. Malek MH, Fonkalsrud EW, Cooper CB. Ventilatory and cardiovascular responses to exercise in patients with pectus excavatum. Chest 124(3):870-82, 2003.
20. Sponseller PD, Hobbs W, Riley LH, 3rd, Pyeritz RE. The thoracolumbar spine in Marfan syndrome. The Journal of Bone and Joint Surgery American 77(6):867-76, 1995.
21. Sponseller PD, Ahn NU, Ahn UM, Nallamshetty L, Rose PS, Kuszyk BS, y col. Osseous anatomy of the lumbosacral spine in Marfan syndrome. Spine (Phila Pa 1976) 25(21):2797-802, 2000.
22. Ahn NU, Ahn UM, Nallamshetty L, Rose PS, Buchowski JM, Garrett ES, y col. The lumbar interpediculate distance is widened in adults with the Marfan syndrome: data from 32 cases. Acta Orthopaedica Scandinavica 72(1):67-71, 2001.
23. Herzka A, Sponseller PD, Pyeritz RE. Atlantoaxial rotatory subluxation in patients with Marfan syndrome. A report of three cases. Spine (Phila Pa 1976) 25(4):524-6, 2000.
24. MacKenzie JM, Rankin R. Sudden death due to atlantoaxial subluxation in marfan syndrome. The American Journal of Forensic Medicine and Pathology 24(4):369-70, 2003.
25. Ahn NU, Nallamshetty L, Ahn UM, Buchowski JM, Rose PS, Garrett ES, y col. Dural ectasia and conventional radiography in the Marfan lumbosacral spine. Skeletal Radiol 30(6):338-45, 2001.
26. Pyeritz RE, Fishman EK, Bernhardt BA, Siegelman SS. Dural ectasia is a common feature of the Marfan syndrome. Am J Hum Genet 43(5):726-32, 1988.
27. Ahn NU, Sponseller PD, Ahn UM, Nallamshetty L, Kuszyk BS, Zinreich SJ. Dural ectasia is associated with back pain in Marfan syndrome. Spine (Phila Pa 1976) 25(12):1562-8, 2000.
28. Bassani L, Graffeo CS, Behrooz N, Tyagi V, Wilson T, Penaranda S, y col. Noninvasive diagnosis and management of spontaneous intracranial hypotension in patients with marfan syndrome: Case report and review of the literature. Surgical Neurology International 5:8, 2014.
29. Haykowsky MJ, Eves ND, DE RW, Findlay MJ. Resistance exercise, the Valsalva maneuver, and cerebrovascular transmural pressure. Med Sci Sports Exerc 35(1):65-8, 2003.
30. Grahame R, Pyeritz RE. The Marfan syndrome: joint and skin manifestations are prevalent and correlated. British Journal of Rheumatology 34(2):126-31, 1995.
31. Wolf JM, Cameron KL, Owens BD. Impact of joint laxity and hypermobility on the musculoskeletal system. The Journal of the American Academy of Orthopaedic Surgeons 19(8):463-71, 2011.
32. Gomes N, Hardy P, Bauer T. Arthroscopic treatment of chronic anterior instability of the shoulder in Marfan's syndrome. Arthroscopy: the Journal of Arthroscopic & Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 23(1):110 e1-5, 2007.
33. Van de Velde S, Fillman R, Yandow S. Protrusio acetabuli in Marfan syndrome: indication for surgery in skeletally immature Marfan patients. J Pediatr Orthop 25(5):603-6, 2005.
34. Smith TO, Jerman E, Easton V, Bacon H, Armon K, Poland F, y col. Do people with benign joint hypermobility syndrome (BJHS) have reduced joint proprioception? A systematic review and meta-analysis. Rheumatology International 33(11):2709-16, 2013.
35. Palmer S, Bailey S, Barker L, Barney L, Elliott A. The effectiveness of therapeutic exercise for joint hypermobility syndrome: a systematic review. Physiotherapy 2013.
36. Banwell HA, Mackintosh S, Thewlis D. Foot orthoses for adults with flexible pes planus: a systematic review. Journal of Foot and Ankle Research 7(1):23, 2014.
37. Jung DY, Koh EK, Kwon OY. Effect of foot orthoses and short-foot exercise on the cross-sectional area of the abductor hallucis muscle in subjects with pes planus: a randomized controlled trial. Journal of Back and Musculoskeletal Rehabilitation 24(4):225-31, 2011.
38. Van de Velde S, Fillman R, Yandow S. Protrusio acetabuli in Marfan syndrome. History, diagnosis, and treatment. The Journal of Bone and Joint Surgery American Volume 88(3):639-46, 2006.
39. Sponseller PD, Jones KB, Ahn NU, Erkula G, Foran JR, Dietz HC, 3rd. Protrusio acetabuli in Marfan syndrome: age-related prevalence and associated hip function. The Journal of Bone and Joint Surgery American Volume 88(3):486-95, 2006.
40. Correa TA, Crossley KM, Kim HJ, Pandy MG. Contributions of individual muscles to hip joint contact force in normal walking. J Biomech 43(8):1618-22, 2010.
41. Kohlmeier L, Gasner C, Bachrach LK, Marcus R. The bone mineral status of patients with Marfan syndrome. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 10(10):1550-5, 1995.
42. Le Parc JM, Molcard S, Tubach F. Bone mineral density in Marfan syndrome. Rheumatology 40(3):358-9, 2001.
43. Carter N, Duncan E, Wordsworth P. Bone mineral density in adults with Marfan syndrome. Rheumatology 39(3):307-9, 2000.
44. Prior JC, Barr SI, Chow R, Faulkner RA. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 5. Physical activity as therapy for osteoporosis. CMAJ: Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne 155(7):940-4, 1996.
45. Vincent KR, Braith RW. Resistance exercise and bone turnover in elderly men and women. Med Sci Sports Exerc 34(1):17-23, 2002.
46. Layne JE, Nelson ME. The effects of progressive resistance training on bone density: a review. Med Sci Sports Exerc 31(1):25-30, 1999.
47. Hind K, Burrows M. Weight-bearing exercise and bone mineral accrual in children and adolescents: a review of controlled trials. Bone 40(1):14-27, 2007.
48. Vincent KR, Braith RW, Feldman RA, Magyari PM, Cutler RB, Persin SA, y col. Resistance exercise and physical performance in adults aged 60 to 83. Journal of the American Geriatrics Society 50(6):1100-7, 2002.
49. Williams MA, Haskell WL, Ades PA, Amsterdam EA, Bittner V, Franklin BA, y col. Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation 116(5):572-84, 2007.
50. Cameron DE, Vricella LA. Valve-sparing aortic root replacement in Marfan syndrome. Seminars in Thoracic and Cardiovascular Surgery Pediatric Cardiac Surgery Annual 103-11, 2005.
51. Savolainen H, Heller G, Fleischmann A, Widmer MK, Carrel TP, Schmidli J. Spontaneous dissection of common iliac artery. A case report. Vascular and Endovascular Surgery 38(3):263-5, 2004.
52. Corone S, Iliou MC, Pierre B, Feige JM, Odjinkem D, Farrokhi T, y col. French registry of cases of type I acute aortic dissection admitted to a cardiac rehabilitation center after surgery. Eur J Cardiovasc Prev Rehabil 16(1):91-5, 2009.
53. Boreham CA, Ferreira I, Twisk JW, Gallagher AM, Savage MJ, Murray LJ. Cardiorespiratory fitness, physical activity, and arterial stiffness: the Northern Ireland Young Hearts Project. Hypertension 44(5):721-6, 2004.
54. Peres P, Bernardelli GF, Mendes CC, Fischer SS, Servantes DM, Medeiros WM, y col. Immediate effects of submaximal effort on pulse wave velocity in patients with Marfan syndrome. Braz J Med Biol Res 43(4):397-402, 2010.
55. Medeiros WM, Peres PA, Carvalho AC, Gun C, De Luca FA. Effect of a physical exercise program in a patient with Marfan syndrome and ventricular dysfunction. Arq Bras Cardiol 98(4):e70-3, 2012.
56. Giske L, Stanghelle JK, Rand-Hendrikssen S, Strom V, Wilhelmsen JE, Roe C. Pulmonary function, working capacity and strength in young adults with Marfan syndrome. J Rehabil Med 35(5):221-8, 2003.
57. Konig P, Boxer R, Morrison J, Pletcher B. Bronchial hyperreactivity in children with Marfan syndrome. Pediatric Pulmonology 11(1):29-36, 1991.
58. Cahalin LP, Arena R, Guazzi M, Myers J, Cipriano G, y col. Inspiratory muscle training in heart disease and heart failure: a review of the literature with a focus on method of training and outcomes. Expert Review of Cardiovascular Therapy 11(2):161-77, 2013.
59. Corrado D, Pelliccia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M, y col. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26(5):516-24, 2005.
60. Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Luna A, Corrado D, Crosson JE, y col. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 109(22):2807-16, 2004.
61. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 45(8):1340-5, 2005.
62. Braverman AC. Exercise and the Marfan syndrome. Med Sci Sports Exerc 30(10 Suppl):S387-95, 1998.
63. Mitchell JH, Haskell W, Snell P, Van Camp SP. Task Force 8: classification of sports. J Am Coll Cardiol 45(8):1364-7, 2005.
64. I National Consensus of Cardiovascular Rehabilitation. Arq Bras Cardiol 69(4):267-91, 1997.

 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
Artículos relacionadosMás relacionadosAtículos relacionados
RECOMENDACIONES EN PACIENTES CON HIPERTENSIÓN EN ESTADIO 1 Y RIESGO BAJO
Hypertension 77(6):58-67
Difundido en siicsalud: 4 ago 2021
EL ÍNDICE GLUCÉMICO Y EL RIESGO DE ENFERMEDAD CARDIOVASCULAR Y MUERTE
New England Journal of Medicine 384:1312-1322
Difundido en siicsalud: 20 ago 2021
RIESGO DE ENFERMEDAD CARDIOVASCULAR FATAL A 10 AÑOS EN RECOLECTORES DE RESIDUOS DE SUDÁFRICA
BMC Cardiovascular Disorders 21(1):1-8
Difundido en siicsalud: 22 jul 2021
ua31618
-->